On Apr. 8, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the FDA for its Smart Detect SARS-CoV-2 rRT-PCR Kit.

This real-time PCR test is intended for the qualitative detection of nucleic acid from SARS-CoV-2, the virus that causes COVID-19, in human nasopharyngeal, anterior nasal and mid-turbinate nasal swab specimens from individuals suspected of COVID-19 by their healthcare provider.